Is this you?
Request access for California Research Foundation with your @crftrials.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
California Research Foundation
Unclaimed profileIndependent Network · San Diego, CA · ~1 sites
Intera lens
ICP 3Lift (cardio sample) 0.07Recruit soph 0.43
Quality Scorecard (1–100)
Overall79Recruit62Ops83Sponsor88Ther85
Performance (observed)
Historical trials
409
Completed
238
Terminated/Withdrawn
43
Completion rate
85%
Active now
119
Phase 2
123
Phase 3
214
Realized enrollment
315,215
First study year
1995
Years active
31
Match confidence
high
Enrollment velocity (inf)
10,168
Therapeutic
Areas
Vaccines (primary), Internal Medicine
Specialties
Internal Medicine, Vaccines (primary focus), all therapeutic areas
Breadth (conditions)
703
Languages
English, Spanish
States
CA
Recruitment (web observed)
Trial Finder
Yes
Patient database
Implied (active recruitment)
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Strong organic presence; 55+ years, 600+ studies, visible leadership positioning
Capability notes
55+ years experience since 1966; hundreds of protocols across internal medicine; vaccine-focused unit; healthy volunteer studies; multiple study phases; pristine data collection emphasis; ethical, quality research focus
Relationships
Sponsors
Pfizer; National Cancer Institute (NCI); Hoffmann-La Roche; SWOG Cancer Research Network; Radiation Therapy Oncology Group; Children's Oncology Group
CROs
Ergomed; ICON Clinical Research; MacroGenics; PRA Health Sciences; Parexel
Owner / parent
Private; family-owned legacy (Brandon family practice origins)
Funding
Family-owned (founded 1966); no PE/VC
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown; PI: Donald M. Brandon, MD
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
Unknown
Tech & DCT
eSource
Yes
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Single-site vaccine specialist with 55+ year legacy. Traditional, quality-focused research model. Weak Intera fit: single location, narrow therapeutic focus (vaccines/Phase I healthy volunteers), limited multi-study capacity, no innovation/recruitment tech signals, traditional approach.
Recommendation features (sample indication)
Ind fit 0.12Liftability 0.07Overall79
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.